SECsense Logo

NeoGenomics, Inc. 8-K Report: Key Insights & Updates for Investors

$NEO
Form 8-K
Filed on: 2025-01-15
Source
NeoGenomics, Inc. 8-K Report: Key Insights & Updates for Investors

Here are the key insights extracted from the provided financial report section:

  1. Company Information:
  • Name: NeoGenomics, Inc.
  • CIK: 0001077183
  • State of Incorporation: Nevada (NV)
  • NASDAQ Symbol: NEO
  • Address: 9490 NeoGenomics Way, Fort Myers, FL 33912
  • Contact Number: (239) 768-0600
  1. Filing Details:
  • Filing Type: 8-K (current report)
  • Filing Date: January 14, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.001
  1. Period of Report:
  • Start Date: January 14, 2025
  • End Date: January 14, 2025
  1. XBRL Information:
  • XBRL Version: 1.0
  • Encoding: UTF-8
  • Schema Reference: neo-20250114.xsd

Insights:

  • The report is a current filing (8-K) which typically indicates important events or changes that shareholders should be aware of, which may include financial results, mergers, acquisitions, or other significant company developments.
  • The specific date of the report suggests it may be an immediate update or disclosure regarding a noteworthy event occurring on that date.
  • The company operates in the biotechnology or life sciences sector, as inferred from its name, which is relevant for market analysis.
  • The minimal par value indicates that it is a common stock, which is typical for companies listed on the NASDAQ.

Overall, this report contains essential information regarding NeoGenomics, including its basic corporate details and the nature of the filing, which are crucial for investors and analysts monitoring the company's regulatory disclosures.